Johnson & Johnson Portfolio Holdings

Johnson & Johnson

  • $293 Million
  • Q4 2024

Johnson & Johnson has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $293 Million distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Protagonist Therapeutics, Inc with a value of $94.5M, Cv Rx, Inc. with a value of $52M, Meira G Tx Holdings PLC with a value of $40.4M, Procept Bio Robotics Corp with a value of $28.8M, and Legend Biotech Corp with a value of $26.5M.

Examining the 13F form we can see an decrease of $20.5M in the current position value, from $314M to 293M.

Johnson & Johnson is based out at New Brunswick, NJ

Below you can find more details about Johnson & Johnson portfolio as well as his latest detailed transactions.

Portfolio value $293 Million
Healthcare: $293 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.89B
$94.5 Million 32.24% of portfolio
2,449,183
Q3 2021 New
$288M
$52 Million 17.73% of portfolio
4,103,430
Q1 2024 Added 17.39%
$307M
$40.4 Million 13.79% of portfolio
6,641,064
Q4 2022 Added 129.12%
$2.92B
$28.8 Million 9.83% of portfolio
357,939
Q4 2022 Reduced 58.57%
$6.52B
$26.5 Million 9.04% of portfolio
814,586
Q2 2023 Reduced 50.0%
$943M
$17.2 Million 5.86% of portfolio
748,062
Q4 2021 New
$138M
$16.1 Million 5.5% of portfolio
5,623,816
Q1 2024 Added 486.04%
$150M
$5.58 Million 1.9% of portfolio
3,379,064
Q3 2021 New
$2.22B
$4.65 Million 1.59% of portfolio
247,598
Q3 2022 Reduced 80.36%
$24.7M
$3.49 Million 1.19% of portfolio
3,636,363
Q2 2024 New
$53.3M
$1.19 Million 0.41% of portfolio
1,074,658
Q3 2021 New
$334M
$1.14 Million 0.39% of portfolio
158,852
Q1 2024 Reduced 50.0%
$106M
$545,000 0.19% of portfolio
311,967
Q1 2024 New
$164M
$526,000 0.18% of portfolio
823,317
Q4 2024 New
$40M
$349,000 0.12% of portfolio
364,472
Q1 2024 Reduced 50.0%
$26.1M
$69,000 0.02% of portfolio
96,866
Q4 2024 Reduced 49.63%
Neumora Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q1 2024 Added 102.76%
Rapport Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q2 2024 New
Contineum Therapeutics Inc.
-
$0 0.0% of portfolio
-
Q2 2024 New

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $293 Million
  • Prior Value $314 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 13, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Johnson & Johnson Portfolio

Follow Johnson & Johnson and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson & Johnson, based on Form 13F filings with the SEC.

News

Stay updated on Johnson & Johnson with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email